1500007I clinical research management; phase 1 clinical trial units for therapeutics against infectious diseases; to 17-0087.B1.0093--07 phase 1 task area B base task order funding; biod can…
Ended Awarded Last action
- Contract number
- HHSN27200006
- Awardee
-
Icon Government And Public Health Solutions, Inc. UEI JHJ7HXD5XR47
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,285,134
Award facts
- Opportunity
-
- NIAIDDMIDNIHAI2013178 Solicitation number
- Contract value 100% obligated
- $1,285,134.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Hinckley, OH 44233, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$30,000 | |
| Funding Only Action | -$156,647 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $30,000 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $1,238,566 | |
| Original award | $203,215 |
Show all 12
About this award
The National Institute of Allergy and Infectious Diseases issued a delivery order to Icon Government and Public Health Solutions, Inc., on January 18, 2018, under the Therapeutics Against Infectious Diseases Phase 1 parent IDIQ, with a ceiling value of $1,285,134.12 for Phase 1 clinical trial unit operations supporting therapeutics against infectious diseases.
Place of performance is Hinckley, OH. The order carries Cost Plus Fixed Fee pricing and carries no set-aside. The award was issued to de-obligate and close expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a), with an ultimate completion date of July 13, 2023.
SCI reporting shows the order invoiced $182 thousand in FY2020, declining to $9 thousand in FY2021 (47 contractor hours), $460 thousand in FY2022 (460 contractor hours, 0.2 FTEs), and $3 thousand in FY2023 (34 contractor hours, 0.0 FTEs). Derived government-paid hourly rates trended downward: $183.32/hr (FY2021), $1,000.66/hr (FY2022), $103.49/hr (FY2023). In FY2023, one subcontractor accounted for 3 percent of contractor hours.
Description
1500007I clinical research management; phase 1 clinical trial units for therapeutics against infectious diseases; to 17-0087.B1.0093--07 phase 1 task area B base task order funding; biod can 8470038; $203,215
Quick answers
Who was awarded contract HHSN27200006?
HHSN27200006 was awarded to Icon Government And Public Health Solutions, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on January 18, 2018.
How much is contract HHSN27200006 worth?
The government has obligated $1,285,134 on HHSN27200006.
Is contract HHSN27200006 an order under another contract?
Yes. HHSN27200006 is a delivery order under HHSN272201500007I, an indefinite delivery contract, on Therapeutics Against Infectious Diseases Phase 1.
Was contract HHSN27200006 competed?
The extent of competition for HHSN27200006 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award